Lifevantage (LFVN) CEO Receives 48,193 Stock Units and 72,289 PRSUs
Rhea-AI Filing Summary
Lifevantage Corp (LFVN) reporting person Steven R. Fife, President and CEO and a director, received non‑derivative and derivative equity awards on 08/26/2025. He was granted 48,193 stock units that represent rights to receive common stock and will hold 659,500 shares beneficially following the grant. He also received 72,289 Performance Restricted Stock Units (PRSUs) at target, with each PRSU representing one share at $0 exercise price; PRSU vesting is contingent on performance and continued service.
The stock units vest partly on September 10, 2026 and then in installments across seven quarters; PRSU vesting, if earned, vests 34% on September 10, 2026, 33% on September 10, 2027 and 33% on September 10, 2028. The Form 4 was signed by a power of attorney on 08/28/2025.
Positive
- Grant of 72,289 PRSUs at $0 exercise price, indicating potential future equity compensation if performance targets are met
- 48,193 stock units granted with specified vesting schedule, increasing reported beneficial ownership to 659,500 shares
- Explicit vesting timeline provided for both time‑based units and PRSUs, with milestones on 09/10/2026, 09/10/2027 and 09/10/2028
Negative
- None.
Insights
TL;DR: CEO received time‑based and performance equity awards that increase his beneficial ownership; these are compensation grants, not open‑market purchases.
The filing shows 48,193 stock units granted and 72,289 PRSUs awarded on 08/26/2025, with no cash price attached. Post‑transaction beneficial ownership is reported as 659,500 shares. The awards include multi‑quarter vesting tied to continued service and PRSU payout tied to performance metrics, with accelerated vesting schedules specified by percentage and dates. This is a routine executive compensation disclosure reflecting equity incentives rather than a direct market transaction.
TL;DR: Grants documented in Form 4 indicate standard long‑term incentive structure with time and performance vesting components.
The report details that the PRSUs are earned based on specified financial performance criteria and that the maximum payout can be up to 200% of target. Vesting schedules are explicit: part of the stock unit award vests on 9/10/2026 with remaining units in seven quarterly installments; earned PRSUs vest over 2026–2028. The filing is properly executed via power of attorney and discloses the post‑grant beneficial ownership figure.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Restricted Stock Units | 72,289 | $0.00 | -- |
| Grant/Award | Common Stock | 48,193 | $0.00 | -- |
Footnotes (1)
- This reflects a stock unit award, in which each stock unit represents a right to receive one share of issuer common stock, which award will vest, subject to the reporting person's continued service with the issuer, as follows: (i) 5/12 of the total number of units will vest on September 10, 2026 and (ii) the remaining units will vest in equal installments as of the 10th day of the third month of each of the seven calendar quarters thereafter. Each Performance Restricted Stock Unit ("PRSU") represents a right to receive one share of issuer common stock, with the total number of units reflecting the number that are eligible to be earned at target-level performance achievement. Upon achievement of the maximum level of the applicable performance criteria, the reporting person may become eligible to earn 200% of the target number of units. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows: (i) 34% of the earned award will vest on September 10, 2026 (ii) 33% of the earned award will vest on September 10, 2027 and (iii) 33% of the earned award will vest on September 10, 2028.